01Overview 02Follow the Money 03Daily Brief 04Live 05Congress 06Corporate Insiders 07Government Money 08Political Influence 09Institutions 10Washington Network 11Follow the Power 12Disclosure Clock 13AI Investigator 14Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…

Overview Follow the Money Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

01Overview 02Follow the Money 03Daily Brief 04Live 05Congress 06Corporate Insiders 07Government Money 08Political Influence 09Institutions 10Washington Network 11Follow the Power 12Disclosure Clock 13AI Investigator 14Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Overview Follow the Money Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Data sources

SEC FORM 46h ago

HOUSE PTR6h ago

SEC 13F6h ago

ROBINHOOD CHAIN6h ago

Public company

IONSIONIS PHARMACEUTICALS INC

CIK 0000874015

EDGAR filings Open in network

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections2with evidence

IONS · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Lobbied forevidence
LMH STRATEGIC SOLUTIONSLDA Q1 2026 first quarter · Health issues · Aug 26, 2026

Lobbying

$300K reported · de-duplicated

2026 Q2 $150K in-house2026 Q1 $150K in-house

In-house report$150K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Taxation, Health issues
In-house report$150K2026 Q1 · posted Aug 26, 2026 · Health issues, Medicare/Medicaid, Taxation
LMH STRATEGIC SOLUTIONS$30K2026 Q2 · posted Aug 26, 2026 · Health issues
LMH STRATEGIC SOLUTIONS$30K2026 Q1 · posted Aug 26, 2026 · Health issues

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.